AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 192 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $271 | -25.8% | 12,000 | -7.7% | 0.00% | -100.0% |
Q4 2022 | $365 | -99.9% | 13,000 | -36.9% | 0.00% | 0.0% |
Q3 2022 | $589,000 | +135.6% | 20,600 | +281.5% | 0.00% | – |
Q3 2021 | $250,000 | -66.1% | 5,400 | -64.0% | 0.00% | -100.0% |
Q1 2021 | $738,000 | -54.3% | 15,000 | -58.6% | 0.00% | 0.0% |
Q4 2020 | $1,614,000 | +472.3% | 36,245 | +342.0% | 0.00% | +100.0% |
Q3 2020 | $282,000 | -74.4% | 8,200 | -60.6% | 0.00% | -66.7% |
Q2 2020 | $1,102,000 | -21.8% | 20,800 | -47.8% | 0.00% | -25.0% |
Q1 2020 | $1,410,000 | +6.8% | 39,813 | +4.0% | 0.00% | 0.0% |
Q3 2019 | $1,320,000 | -21.6% | 38,300 | +13.5% | 0.00% | -20.0% |
Q2 2019 | $1,683,000 | -50.4% | 33,737 | -32.9% | 0.01% | -50.0% |
Q1 2019 | $3,392,000 | +118.8% | 50,300 | +47.1% | 0.01% | +150.0% |
Q4 2018 | $1,550,000 | +2.4% | 34,200 | +18.4% | 0.00% | -33.3% |
Q2 2017 | $1,514,000 | +8.2% | 28,885 | +18.4% | 0.01% | -25.0% |
Q1 2017 | $1,399,000 | +235.5% | 24,400 | +144.0% | 0.01% | +300.0% |
Q4 2016 | $417,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |